Mirae Asset Global ETFs Holdings
CGON icon

Mirae Asset Global ETFs Holdings’s CG Oncology CGON Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.07M Buy
45,615
+2,488
+6% +$141K ﹤0.01% 1000
2025
Q4 		$1.78M Buy
43,127
+3,209
+8% +$133K ﹤0.01% 1210
2025
Q3 		$1.6M Sell
39,918
-4,410
-10% -$128K ﹤0.01% 1245
2025
Q2 		$1.15M Buy
44,328
+8,806
+25% +$212K ﹤0.01% 1382
2025
Q1 		$876K Buy
35,522
+5,442
+18% +$153K ﹤0.01% 1568
2024
Q4 		$862K Buy
30,080
+1,026
+4% +$35.1K ﹤0.01% 1624
2024
Q3 		$1.1M Buy
29,054
+15,746
+118% +$552K ﹤0.01% 1493
2024
Q2 		$418K Buy
+13,308
New +$461K ﹤0.01% 1908

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mirae Asset Global ETFs Holdings's CGON Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its CG Oncology (CGON) stake by 5.8% in Q1 2026, buying an estimated $141K and bringing the position to 45,615 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1000.

Mirae Asset Global ETFs Holdings first reported a position in CGON in Q2 2024 and has held it in 8 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 45,615 shares of CG Oncology worth $3.07M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 2,488 CG Oncology shares in Q1 2026, an estimated $141K.
  • CG Oncology made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1000 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in CG Oncology in Q2 2024 and has held it in 8 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.